COR
Price
$227.74
Change
+$1.47 (+0.65%)
Updated
Dec 20, 04:59 PM (EDT)
39 days until earnings call
SHTDF
Price
$2.49
Change
-$0.06 (-2.35%)
Updated
Dec 20 closing price
Ad is loading...

COR vs SHTDF

Header iconCOR vs SHTDF Comparison
Open Charts COR vs SHTDFBanner chart's image
Cencora
Price$227.74
Change+$1.47 (+0.65%)
Volume$15.16K
CapitalizationN/A
Sinopharm Group
Price$2.49
Change-$0.06 (-2.35%)
Volume$100
CapitalizationN/A
COR vs SHTDF Comparison Chart
Loading...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
COR vs. SHTDF commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COR is a Hold and SHTDF is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (COR: $227.69 vs. SHTDF: $2.49)
Brand notoriety: COR and SHTDF are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: COR: 158% vs. SHTDF: 11%
Market capitalization -- COR: $48.42B vs. SHTDF: $9.79B
COR [@Medical Distributors] is valued at $48.42B. SHTDF’s [@Medical Distributors] market capitalization is $9.79B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COR’s FA Score shows that 3 FA rating(s) are green whileSHTDF’s FA Score has 1 green FA rating(s).

  • COR’s FA Score: 3 green, 2 red.
  • SHTDF’s FA Score: 1 green, 4 red.
According to our system of comparison, COR is a better buy in the long-term than SHTDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COR’s TA Score shows that 5 TA indicator(s) are bullish while SHTDF’s TA Score has 2 bullish TA indicator(s).

  • COR’s TA Score: 5 bullish, 5 bearish.
  • SHTDF’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, COR is a better buy in the short-term than SHTDF.

Price Growth

COR (@Medical Distributors) experienced а -1.96% price change this week, while SHTDF (@Medical Distributors) price change was -2.35% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.86%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was +147.05%.

Reported Earning Dates

COR is expected to report earnings on Jan 30, 2025.

Industries' Descriptions

@Medical Distributors (+0.86% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
COR($48.4B) has a higher market cap than SHTDF($9.79B). COR has higher P/E ratio than SHTDF: COR (26.47) vs SHTDF (8.00). COR YTD gains are higher at: 11.848 vs. SHTDF (0.000). SHTDF has higher annual earnings (EBITDA): 24.7B vs. COR (3.71B). SHTDF has more cash in the bank: 43.5B vs. COR (2.87B). COR has less debt than SHTDF: COR (4.78B) vs SHTDF (68.4B). SHTDF has higher revenues than COR: SHTDF (521B) vs COR (272B).
CORSHTDFCOR / SHTDF
Capitalization48.4B9.79B495%
EBITDA3.71B24.7B15%
Gain YTD11.8480.000-
P/E Ratio26.478.00331%
Revenue272B521B52%
Total Cash2.87B43.5B7%
Total Debt4.78B68.4B7%
FUNDAMENTALS RATINGS
COR vs SHTDF: Fundamental Ratings
COR
SHTDF
OUTLOOK RATING
1..100
6150
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
19
Undervalued
PROFIT vs RISK RATING
1..100
2100
SMR RATING
1..100
1058
PRICE GROWTH RATING
1..100
5650
P/E GROWTH RATING
1..100
3254
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SHTDF's Valuation (19) in the null industry is significantly better than the same rating for COR (94) in the Real Estate Investment Trusts industry. This means that SHTDF’s stock grew significantly faster than COR’s over the last 12 months.

COR's Profit vs Risk Rating (2) in the Real Estate Investment Trusts industry is significantly better than the same rating for SHTDF (100) in the null industry. This means that COR’s stock grew significantly faster than SHTDF’s over the last 12 months.

COR's SMR Rating (10) in the Real Estate Investment Trusts industry is somewhat better than the same rating for SHTDF (58) in the null industry. This means that COR’s stock grew somewhat faster than SHTDF’s over the last 12 months.

SHTDF's Price Growth Rating (50) in the null industry is in the same range as COR (56) in the Real Estate Investment Trusts industry. This means that SHTDF’s stock grew similarly to COR’s over the last 12 months.

COR's P/E Growth Rating (32) in the Real Estate Investment Trusts industry is in the same range as SHTDF (54) in the null industry. This means that COR’s stock grew similarly to SHTDF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CORSHTDF
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
79%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
67%
Momentum
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
72%
MACD
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
58%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
64%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
63%
Advances
ODDS (%)
Bullish Trend 10 days ago
62%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
44%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
71%
Bullish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
60%
Bearish Trend 3 days ago
56%
View a ticker or compare two or three
Ad is loading...
COR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SHTDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CSMFX25.680.35
+1.38%
Carillon Scout Mid Cap C
BGLKX34.030.43
+1.28%
Baillie Gifford Long Term Global Gr K
VWUSX72.680.68
+0.94%
Vanguard US Growth Investor
BRSDX14.720.12
+0.82%
MFS Blended Research Small Cap Eq A
LGCYX16.750.12
+0.72%
Lord Abbett Global Equity I

COR and

Correlation & Price change

A.I.dvisor indicates that over the last year, COR has been loosely correlated with MCK. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if COR jumps, then MCK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COR
1D Price
Change %
COR100%
+0.63%
MCK - COR
59%
Loosely correlated
+0.09%
CAH - COR
55%
Loosely correlated
+1.09%
OMI - COR
22%
Poorly correlated
-0.79%
SHTDF - COR
17%
Poorly correlated
-2.35%
HSIC - COR
11%
Poorly correlated
+1.26%
More

SHTDF and

Correlation & Price change

A.I.dvisor tells us that SHTDF and SHTDY have been poorly correlated (+19% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SHTDF and SHTDY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SHTDF
1D Price
Change %
SHTDF100%
-2.35%
SHTDY - SHTDF
19%
Poorly correlated
-0.71%
COR - SHTDF
17%
Poorly correlated
+0.63%
SHPMY - SHTDF
12%
Poorly correlated
N/A
CAH - SHTDF
12%
Poorly correlated
+1.09%
AHG - SHTDF
10%
Poorly correlated
+3.36%
More